Skip to main content
logo
PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
62.82
-0.51 (-0.81%)
At close: Mar 6, 2026, 4:00 PM EST
63.00
+0.18 (0.29%)
After-hours: Mar 6, 2026, 5:12 PM EST

PTC Therapeutics Revenue by Segment

Period EndingDec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Collaboration
998.36M998.73M1.09B1.09B100.36M---150.08M--50.06M75.08M---
Collaboration Growth
894.76%565.49%2,076.48%1,347.19%17.98%---172.60%---19.99%3.51%---
Net Product
586.70M557.42M561.88M576.77M600.95M601.31M609.92M651.30M
Net Product Growth
-2.37%-7.30%-7.88%-11.44%-9.12%-5.11%-2.23%9.84%
Royalty
244.22M223.00M213.57M209.15M203.86M196.70M185.51M169.18M--
Royalty Growth
19.80%13.37%15.13%23.63%20.73%24.71%32.05%34.85%--
Manufacturing
-96.00M-----5.00M7.06M7.69M------------

Revenue by Product

Period EndingDec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Translarna
235.30M290.17M311.80M322.70M340.30M321.50M318.20M344.30M
Translarna Growth
-30.86%-9.75%-2.01%-6.27%-4.36%-4.43%-7.50%6.10%
Emflaza
146.36M169.56M186.30M197.20M206.70M224.10M239.60M258.00M
Emflaza Growth
-29.19%-24.34%-22.25%-23.57%-18.97%-8.83%2.74%15.02%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.